Candida albicans translocation through the intestinal epithelial barrier is promoted by fungal zinc acquisition and limited by NFκB-mediated barrier protection.


Journal

PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921

Informations de publication

Date de publication:
Mar 2024
Historique:
received: 20 07 2023
accepted: 06 02 2024
medline: 4 3 2024
pubmed: 1 3 2024
entrez: 1 3 2024
Statut: epublish

Résumé

The opportunistic fungal pathogen Candida albicans thrives on human mucosal surfaces as a harmless commensal, but frequently causes infections under certain predisposing conditions. Translocation across the intestinal barrier into the bloodstream by intestine-colonizing C. albicans cells serves as the main source of disseminated candidiasis. However, the host and microbial mechanisms behind this process remain unclear. In this study we identified fungal and host factors specifically involved in infection of intestinal epithelial cells (IECs) using dual-RNA sequencing. Our data suggest that host-cell damage mediated by the peptide toxin candidalysin-encoding gene ECE1 facilitates fungal zinc acquisition. This in turn is crucial for the full virulence potential of C. albicans during infection. IECs in turn exhibit a filamentation- and damage-specific response to C. albicans infection, including NFκB, MAPK, and TNF signaling. NFκB activation by IECs limits candidalysin-mediated host-cell damage and mediates maintenance of the intestinal barrier and cell-cell junctions to further restrict fungal translocation. This is the first study to show that candidalysin-mediated damage is necessary for C. albicans nutrient acquisition during infection and to explain how IECs counteract damage and limit fungal translocation via NFκB-mediated maintenance of the intestinal barrier.

Identifiants

pubmed: 38427950
doi: 10.1371/journal.ppat.1012031
pii: PPATHOGENS-D-23-01201
pmc: PMC10907035
doi:

Substances chimiques

Zinc J41CSQ7QDS

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1012031

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/V033417/1
Pays : United Kingdom
Organisme : NIDCR NIH HHS
ID : R01 DE022550
Pays : United States
Organisme : NIDCR NIH HHS
ID : R37 DE022550
Pays : United States

Informations de copyright

Copyright: © 2024 Sprague et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Biomolecules. 2022 Jun 27;12(7):
pubmed: 35883455
Mol Microbiol. 2003 Mar;47(6):1523-43
pubmed: 12622810
Nat Rev Dis Primers. 2018 May 11;4:18026
pubmed: 29749387
Curr Opin Microbiol. 2020 Aug;56:7-15
pubmed: 32604030
mSystems. 2022 Dec 20;7(6):e0053922
pubmed: 36264075
Gut Microbes. 2022 Jan-Dec;14(1):2154548
pubmed: 36503341
Bioorg Med Chem. 2003 Feb 6;11(3):383-91
pubmed: 12517433
Nat Med. 2020 Jan;26(1):59-64
pubmed: 31907459
Sci Signal. 2022 Apr 5;15(728):eabj6915
pubmed: 35380879
Int J Med Microbiol. 2021 Apr;311(3):151490
pubmed: 33676239
Nutrients. 2020 Mar 13;12(3):
pubmed: 32183116
Proc Natl Acad Sci U S A. 2012 Aug 28;109(35):14194-9
pubmed: 22891338
Sci Rep. 2016 Nov 03;6:36055
pubmed: 27808111
Mol Microbiol. 2005 Mar;55(5):1553-65
pubmed: 15720560
Gene. 1987;57(2-3):267-72
pubmed: 3319781
Curr Opin Microbiol. 2019 Dec;52:100-109
pubmed: 31288097
Cell Host Microbe. 2010 Sep 16;8(3):225-35
pubmed: 20833374
Front Microbiol. 2012 Mar 12;3:85
pubmed: 22416242
J Cell Sci. 1992 Jul;102 ( Pt 3):581-600
pubmed: 1506435
Curr Treat Options Infect Dis. 2022 Jun;14(2):15-34
pubmed: 36329878
Microb Pathog. 2003 Apr;34(4):169-77
pubmed: 12668140
PLoS Pathog. 2021 Jan 20;17(1):e1009221
pubmed: 33471869
Cell Death Differ. 2006 May;13(5):759-72
pubmed: 16410803
Nat Commun. 2015 Mar 31;6:6741
pubmed: 25824284
Nat Microbiol. 2021 May;6(5):643-657
pubmed: 33753919
J Infect Dis. 2014 Jun 1;209(11):1816-26
pubmed: 24357630
Curr Biol. 2009 Mar 10;19(5):436-41
pubmed: 19249212
Cell Microbiol. 2013 Jul;15(7):1198-211
pubmed: 23320394
Nat Commun. 2019 May 24;10(1):2297
pubmed: 31127085
Cell. 1997 Sep 5;90(5):939-49
pubmed: 9298905
J Hosp Infect. 2009 May;72(1):9-16
pubmed: 19303662
J Biol Chem. 2022 Oct;298(10):102419
pubmed: 36037968
PLoS Genet. 2016 Jun 24;12(6):e1006142
pubmed: 27341673
Toxins (Basel). 2022 Dec 15;14(12):
pubmed: 36548771
Autophagy. 2022 Nov;18(11):2761-2762
pubmed: 35443855
PLoS One. 2011;6(7):e21800
pubmed: 21789182
Nucleic Acids Res. 2012 Jan;40(Database issue):D675-81
pubmed: 22064857
BMC Genomics. 2017 Sep 6;18(1):696
pubmed: 28874114
Genome Biol. 2010;11(10):R106
pubmed: 20979621
PLoS Genet. 2014 Dec 04;10(12):e1004824
pubmed: 25474009
N Engl J Med. 2015 Oct 8;373(15):1445-56
pubmed: 26444731
Yeast. 2007 Oct;24(10):847-60
pubmed: 17605131
mBio. 2023 Apr 25;14(2):e0009523
pubmed: 36912640
PLoS One. 2013;8(3):e58613
pubmed: 23516516
PLoS Pathog. 2012;8(6):e1002777
pubmed: 22761575
mBio. 2020 Oct 6;11(5):
pubmed: 33024045
Cell Microbiol. 2007 Dec;9(12):2938-54
pubmed: 17645752
Expert Rev Anti Infect Ther. 2017 Apr;15(4):327-330
pubmed: 28152317
Bioorg Med Chem Lett. 2007 Nov 1;17(21):5858-62
pubmed: 17869512
Cell Microbiol. 2016 Jul;18(7):889-904
pubmed: 26752615
PLoS One. 2011 Feb 23;6(2):e17046
pubmed: 21407800
Cell Host Microbe. 2021 Jun 9;29(6):867-878
pubmed: 34111395
FEMS Microbiol Rev. 2021 Sep 8;45(5):
pubmed: 33524102
Cell Rep. 2022 Jan 4;38(1):110187
pubmed: 34986345
Exp Mol Med. 2021 Oct;53(10):1471-1482
pubmed: 34663936
Mol Gen Genet. 1984;198(2):179-82
pubmed: 6394964
Nat Commun. 2022 Jun 9;13(1):3192
pubmed: 35680868
PLoS Biol. 2015 Feb 18;13(2):e1002076
pubmed: 25693184
mBio. 2018 Jun 5;9(3):
pubmed: 29871918
PLoS Biol. 2009 Jun;7(6):e1000133
pubmed: 19529758
Science. 2008 Feb 15;319(5865):962-5
pubmed: 18276893
FEMS Yeast Res. 2006 Nov;6(7):1085-93
pubmed: 17042758
PLoS Pathog. 2018 May 4;14(5):e1007013
pubmed: 29727465
J Clin Biochem Nutr. 2019 Mar;64(2):170-173
pubmed: 30936630
Mycoses. 2015 Oct;58 Suppl 5:22-8
pubmed: 26449503
Nat Genet. 2010 Jul;42(7):590-8
pubmed: 20543849
J Microbiol Biotechnol. 2008 Feb;18(2):242-7
pubmed: 18309267
Nature. 2016 Apr 7;532(7597):64-8
pubmed: 27027296
Nat Rev Mol Cell Biol. 2007 Jan;8(1):49-62
pubmed: 17183360
Cell Microbiol. 2021 Oct;23(10):e13378
pubmed: 34245079
Clin Infect Dis. 2001 Dec 15;33(12):1959-67
pubmed: 11702290

Auteurs

Jakob L Sprague (JL)

Department of Microbial Pathogenicity Mechanisms, Hans-Knöll-Institute, Jena, Germany.

Tim B Schille (TB)

Department of Microbial Pathogenicity Mechanisms, Hans-Knöll-Institute, Jena, Germany.
Cluster of Excellence Balance of the Microverse, Friedrich-Schiller-University Jena, Jena, Germany.

Stefanie Allert (S)

Department of Microbial Pathogenicity Mechanisms, Hans-Knöll-Institute, Jena, Germany.

Verena Trümper (V)

Department of Microbial Pathogenicity Mechanisms, Hans-Knöll-Institute, Jena, Germany.

Adrian Lier (A)

Department of Microbial Pathogenicity Mechanisms, Hans-Knöll-Institute, Jena, Germany.

Peter Großmann (P)

Department of Microbiome Dynamics, Hans-Knöll-Institute, Jena, Germany.

Emily L Priest (EL)

Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral and Craniofacial Sciences, King's College London, London, United Kingdom.

Antzela Tsavou (A)

Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral and Craniofacial Sciences, King's College London, London, United Kingdom.

Gianni Panagiotou (G)

Cluster of Excellence Balance of the Microverse, Friedrich-Schiller-University Jena, Jena, Germany.
Department of Microbiome Dynamics, Hans-Knöll-Institute, Jena, Germany.
Institute of Microbiology, Friedrich-Schiller-University Jena, Jena, Germany.

Julian R Naglik (JR)

Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral and Craniofacial Sciences, King's College London, London, United Kingdom.

Duncan Wilson (D)

Medical Research Council, Centre for Medical Mycology at the University of Exeter, Exeter, United Kingdom.

Sascha Schäuble (S)

Department of Microbiome Dynamics, Hans-Knöll-Institute, Jena, Germany.

Lydia Kasper (L)

Department of Microbial Pathogenicity Mechanisms, Hans-Knöll-Institute, Jena, Germany.

Bernhard Hube (B)

Department of Microbial Pathogenicity Mechanisms, Hans-Knöll-Institute, Jena, Germany.
Cluster of Excellence Balance of the Microverse, Friedrich-Schiller-University Jena, Jena, Germany.
Institute of Microbiology, Friedrich-Schiller-University Jena, Jena, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH